|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.25 GBX | +9.41% |
|
+19.23% | +97.87% |
| May. 03 | Angle shares up on assay development deal with AstraZeneca | AN |
| May. 03 | Angle shares up on assay development deal with AstraZenaca | AN |
(via NewsDirect)
The partnership will see the two firms develop to create a circulating tumour cell (CTC) HER2 assay for breast cancer that could ultimately enable hospitals worldwide to access technology that measures HER2 status in breast cancer patients.
+44 20 7989 0813
uk@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Copyright (c) 2023 TheNewswire - All rights reserved., source
| 1st Jan change | Capi. | |
|---|---|---|
| +97.87% | 69.64M | |
| -12.09% | 19.25B | |
| -39.00% | 2.96B | |
| +22.02% | 1.96B | |
| -0.62% | 1.69B | |
| +33.51% | 1.27B | |
| -16.17% | 982M | |
| -22.01% | 913M | |
| +5.38% | 801M | |
| -23.80% | 630M |
ANGLE PLC 
